{
  "id": "981f4e527c3b20ac",
  "title": "FDA denies tolebrutinib approval for nonrelapsing progressive MS | Multiple Sclerosis News Today",
  "description": "20251229T164500Z",
  "content": "",
  "source": "multiplesclerosisnewstoday.com",
  "source_url": "https://multiplesclerosisnewstoday.com/news-posts/2025/12/29/fda-denies-tolebrutinib-approval-nonrelapsing-progressive-ms/",
  "published_at": "20251229T164500Z",
  "fetched_at": "2025-12-30T00:22:59.073919+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://multiplesclerosisnewstoday.com/news-posts/2025/12/29/fda-denies-tolebrutinib-approval-nonrelapsing-progressive-ms/",
    "url_mobile": "",
    "title": "FDA denies tolebrutinib approval for nonrelapsing progressive MS | Multiple Sclerosis News Today",
    "seendate": "20251229T164500Z",
    "socialimage": "https://multiplesclerosisnewstoday.com/wp-content/uploads/2025/12/Thumbsdown_Circle.png",
    "domain": "multiplesclerosisnewstoday.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}